🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, alleging the corporations withheld potential risks that the medication posed to pediatric cognitive development.

The court filing follows thirty days after Donald Trump promoted an unproven link between taking Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the exclusive pain medication approved for women during pregnancy, and Kenvue, which currently produces it.

In a statement, he claimed they "betrayed America by making money from discomfort and marketing drugs ignoring the potential hazards."

The manufacturer says there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations lied for decades, intentionally threatening millions to line their pockets," Paxton, from the Republican party, said.

The manufacturer commented that it was "very worried by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the well-being of US mothers and children."

On its online platform, the company also stated it had "continuously evaluated the relevant science and there is no credible data that shows a verified association between using acetaminophen and autism."

Organizations acting on behalf of doctors and healthcare providers concur.

ACOG has declared paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to address pain and elevated temperature, which can present serious health risks if ignored.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the consumption of acetaminophen in any trimester of gestation leads to neurodevelopmental disorders in children," the group said.

The lawsuit references current declarations from the former administration in arguing the drug is reportedly hazardous.

In recent weeks, the former president caused concern from public health officials when he told pregnant women to "fight like hell" not to consume acetaminophen when ill.

Federal regulators then released a statement that physicians should contemplate reducing the usage of acetaminophen, while also stating that "a causal relationship" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "extensive scientific investigation" that would determine the source of autism in a short period.

But authorities advised that identifying a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism is a form of permanent neurological difference and impairment that influences how people perceive and interact with the surroundings, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is campaigning for the Senate - claims the manufacturer and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "remove any marketing or advertising" that states acetaminophen is safe for expectant mothers.

This legal action mirrors the grievances of a group of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in 2022.

The court dismissed the case, saying studies from the plaintiffs' authorities was lacking definitive proof.